Specialty Chemicals
Specialty Chemicals
|
CMO / Process Intensification
7× Throughput Increase in Same Footprint
- Scale-up — 300 MTs/yr → 2,100 MTs/yr within same footprint, minimal investment
- Technology — Batch → CSTR-in-series, Continuous Extraction, custom flow reactor
- Speed — All transformations achieved with just 15-day plant shutdown
Specialty Chemicals
|
CMO / Process Intensification
Hazardous Batch → Continuous Fixed-Bed Reactor
- Safety — Safe operation to 50 bar / 250°C; improved conversion & selectivity
- Scope — Aromatic saturation, azide/nitro-to-amine, reductive amination
- Technology — Higher catalyst-to-substrate ratio; eliminated mass-transfer bottlenecks
Specialty Chemicals
|
CMO
Breakthrough Quality — 20+ Year Stable Process Improved
- Application — Specialty additive for Automotive; optimised over 20+ years
- Result — Significant, measurable quality improvement in just 6 months
- Recognition — Large European customer: no other CMO had achieved this
Specialty Chemicals
|
CMO / CDMO
Crystal Size Distribution — Silo Bottleneck Eliminated
- Solution — Redesigned crystallization: nucleation, supersaturation & cooling ramp
- Result — Eliminated bridging/ratholing; batch cycle time significantly reduced
Life Sciences & Healthcare
Life Sciences
|
CRO
"Amazing" Raw Material Cost Reduction: $160+ → <$70/kg
- Molecule — Pre-launch active — 7-step synthesis
- Saving — $90+/kg reduction in raw material cost
- Customer remark — "Amazed that such savings could be achieved"
Life Sciences
|
CDMO
Sudden Phase Change Solved — Novel Reactor Design
- Challenge — Phase change causing agitation to stop — safety & yield risk
- Solution — Novel reactor design engineered to resolve phase change
- Result — Improved yield delivered safely at commercial scale
Life Sciences
|
CDMO
Big CMOs Failed — Inventys Delivered — Chiral Amino Acid
- Result — 98% yield vs. 70% achieved by large CMOs
- Innovation — Chiral separation without a chiral separation agent
- Scale — ~300 MTs/yr; 210+ minor & 16 major challenges resolved
Life Sciences
|
CDMO
Inventys Material Selected for Active Registration
- Scope — 4 intermediates developed & piloted within 6 months
- AI — Produced by selected route for regulatory registration
- Launch — Significantly improved originator time-to-market (2030)
Animal Health
Animal Health
|
CRO / CDMO
Large Price Reduction: $2,500/kg → $1,200/kg
- Active — Animal health molecule — commercial launch post-2034
- Saving — 52% cost reduction
- Approach — Backward integration + systematic process improvement
Animal Health
|
CDMO
Millions Saved in CapEx — Improved Patented Hydrogenation
- Breakthrough — Hydrogenation pressure: 60 atm → 10 atm
- Result — Significantly reduced catalyst loading & CapEx
- Quality — Full product quality and yield maintained
Crop Protection
Crop Protection
|
CMO
Rapid TechPack → Commercial in 7 Months
- Complexity — 4 chemical transformations across 14 reactors
- Speed — Lab → Pilot → Plant Modification → Commercial in 7 months
- Result — Full first-year production (30 MTs/yr) delivered ahead of schedule
Crop Protection
|
CDMO
Globally Cost-Competitive Process — Big 5 Originator
- Context — Active off-patent in China; expiring US/Europe within 2 years
- Innovation — Flow & Semi-Continuous Process for world-competitive economics
- Scale — ~400 → ~750 MTs/yr
Crop Protection
|
CDMO
30% Cost Reduction & n-BuLi Handling Eliminated
- Safety — Elegant alternative route eliminates hazardous n-BuLi usage
- Economics — 30% cost reduction with minimal additional CapEx
Crop Protection
|
CDMO
New Route of Synthesis — Active Registration (Launch 2029/2030)
- Innovation — New RoS removes need for expensive reagent
- Regulatory — 4 intermediates developed; AI produced for registration
- Speed — Piloted in 6 months; improves originator time-to-market
Flow Chemistry & Process Intensification — Cross-Industry
| Metric | Achievement |
|---|---|
| Throughput | 64× increase — from 1 MT/month to 64 MTs/month |
| Solvent Usage | 91% reduction via process intensification |
| Energy Usage | 90% reduction via flow chemistry |
| Lithiation Temperature | Raised from −78°C to −10°C — safer & lower cost operation |
| Footprint Efficiency | 300 MT/yr → 2,100 MT/yr in the same physical footprint |
| Gas Phase Reaction | 360°C reaction, carbon economy = 1; 3,000 MT/yr plant commissioned 2019 |
| Implemented | Lithiation–Azidation & Telescoping Synthesis at commercial scale |
Sustainability Leadership
Recognised as best-in-class across the global specialty chemicals industry
>51%
Renewable Energy
NET ZERO carbon impact maintained continuously since 2012 — over a decade of clean energy leadership
~90%
Raw Materials from India
Deep backward integration eliminating critical supply chain dependencies and ensuring resilient, local sourcing
2022
FICCI Best Green Process
Federation of Indian Chamber of Commerce & Industries — Best Green Process Award for process innovation
89
TfS Score
Together for Sustainability assessment score, reflecting best-in-class environmental and social governance
Bronze
EcoVadis Rating
EcoVadis Bronze sustainability rating recognising robust environmental, labour, and ethics standards
ZERO
Lot Rejections Since 2011
Unbroken quality record across 5,000+ MTs and 18+ products — a testament to disciplined manufacturing culture
ISO 9001
ISO 14001
ISO 45000
ISO 50001
ISO 27001
ISO 37001
ISO 26001
WHO GMP
CDSCO
US FDA
"Best sustainability performance seen so far — across our entire global supplier network."
— $30+ Billion Global Healthcare Company